Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Valenza

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Drug Intelligence & Clinical Pharmacy|December 1, 1983
A new programmable calculator procedure for individualizing phenytoin dosageA Messori, T Valenza, G Zaccara, et al.
Therapeutic Drug Monitoring|January 1, 1985
Effect of associated antiepileptic treatment on valproate-induced hyperammonemiaG Zaccara, M Paganini, R Campostrini, et al.
Neurology|November 1, 1984
Acute changes of blood ammonia may predict short-term adverse effects of valproic acidG Zaccara, R Campostrini, M Paganini, et al.
Journal of Clinical and Hospital Pharmacy|December 1, 1983
Comparative analysis of the pharmacokinetic techniques available for individualizing phenytoin dosageA Messori, G Zaccara, T Valenza, et al.
Journal of Endocrinological Investigation|August 1, 1987
Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytomaM Mannelli, M L De Feo, M Maggi, et al.
Epilepsy Research|May 1, 1989
Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsyG Zaccara, A Messori, G C Muscas, et al.
Italian Journal of Neurological Sciences|June 1, 1984
Clinical application of the Mullen and Foster method for individualizing phenytoin dosageT Valenza, A Messori, G Zaccara, et al.
Recenti Progressi in Medicina|March 1, 1989
Pyrrolidone carboxylic acid in acute and chronic alcoholism. Preclinical and clinical studiesD E Pellegrini-Giampietro, F Moroni, A Pistelli, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Drug Intelligence & Clinical Pharmacy|December 1, 1983
A new programmable calculator procedure for individualizing phenytoin dosageA Messori, T Valenza, G Zaccara, et al.
Therapeutic Drug Monitoring|January 1, 1985
Effect of associated antiepileptic treatment on valproate-induced hyperammonemiaG Zaccara, M Paganini, R Campostrini, et al.
Neurology|November 1, 1984
Acute changes of blood ammonia may predict short-term adverse effects of valproic acidG Zaccara, R Campostrini, M Paganini, et al.
Journal of Clinical and Hospital Pharmacy|December 1, 1983
Comparative analysis of the pharmacokinetic techniques available for individualizing phenytoin dosageA Messori, G Zaccara, T Valenza, et al.
Journal of Endocrinological Investigation|August 1, 1987
Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytomaM Mannelli, M L De Feo, M Maggi, et al.
Epilepsy Research|May 1, 1989
Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsyG Zaccara, A Messori, G C Muscas, et al.
Italian Journal of Neurological Sciences|June 1, 1984
Clinical application of the Mullen and Foster method for individualizing phenytoin dosageT Valenza, A Messori, G Zaccara, et al.
Recenti Progressi in Medicina|March 1, 1989
Pyrrolidone carboxylic acid in acute and chronic alcoholism. Preclinical and clinical studiesD E Pellegrini-Giampietro, F Moroni, A Pistelli, et al.
Pageof 2